“…Poly(2-methoxyethyl acrylate) (PMEA), a water-insoluble polymer, is a biomaterial coating; , substrates coated with PMEA possess the properties of antithrombogenicity and cell adhesivity based on the modulation of protein adsorption and conformational changes in the presence of serum proteins. PMEA suppresses the adsorption and conformational changes of fibrinogen, which plays a key role in blood clot formation, while enhancing the conformational change in adsorbed fibronectin (FN), an adhesive protein containing the RGD sequence. − The profiles of adsorbed proteins on PMEA substrates inhibited the adhesion of platelets and enhanced the adhesion of cells, such as fibroblasts, hepatocytes, adipocytes, endothelial cells, and tumor cells. − Furthermore, we discovered that the number of adhered cells on PMEA substrates increased with the expression of integrin α5 and β3 . Because integrin expression in tumor cells is relatively higher than that in normal cells, PMEA substrates could be used to isolate tumor cells. , Currently, CTCs are mainly collected using specific antibody-conjugated substrates; however, PMEA has the potential to isolate tumor cells including CTCs from whole blood without using antibodies, thus allowing the label-free isolation of tumor cells.…”